Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DCAF15 is a substrate receptor component of the cullin-RING E3 ubiquitin ligase complex, specifically associated with the CUL4-DDB1 complex. It acts as an adaptor protein that recognizes specific substrates for ubiquitination and subsequent proteasomal degradation. It is involved in the regulation of cell processes, including cell proliferation, migration, and invasion, and plays a role in natural killer cell activation.
Acts as an adaptor to bring E3 ubiquitin ligase complex (CRL4) and specific substrates (e.g., ZEB1, RBM39) together, leading to substrate polyubiquitination and proteasomal degradation. Some small molecules can act as "molecular glues" to redirect DCAF15 to new substrates.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 15.